{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:40:08Z","timestamp":1748972408691,"version":"3.41.0"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>This grand round describes the case of a patient who received 10 grams (143.5 mg\/kg) of vancomycin every 24 hours via continuous infusion, in whom the highest observed level was only 15.4 mg\/L. Despite subtherapeutic levels, renal impairment was encountered, which resolved after the discontinuation of vancomycin. Glomerular hyperfiltration was found through nuclear glomerular filtration rate measurement, which likely explains the need for high doses (&gt;6 grams per 24 hours continuous infusion) without reaching therapeutic serum levels.<\/jats:p>","DOI":"10.1097\/ftd.0000000000001061","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T15:45:21Z","timestamp":1675352721000},"page":"136-139","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["An Unusual Case of Low Vancomycin Exposure Despite Extremely High Vancomycin Doses Accompanied by Renal Toxicity: A Grand Round"],"prefix":"10.1097","volume":"45","author":[{"given":"Anne M.","family":"van Schip","sequence":"first","affiliation":[{"name":"Amsterdam UMC, Department of Hospital Pharmacy and Clinical Pharmacology, University of Amsterdam, Amsterdam, the Netherlands; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeske J. K.","family":"van Diemen","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, Division of Infectious Diseases, Department of Internal Medicine, University of Amsterdam, Amsterdam the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinier M.","family":"van Hest","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, Department of Hospital Pharmacy and Clinical Pharmacology, University of Amsterdam, Amsterdam, the Netherlands; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa C.","family":"Harris","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, Division of Infectious Diseases, Department of Internal Medicine, University of Amsterdam, Amsterdam the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,1,2]]},"reference":[{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"e79603","DOI":"10.1371\/journal.pone.0079603","article-title":"Pharmacokinetics of drugs in cachectic patients: a systematic review","volume":"8","author":"Trobec","year":"2013","journal-title":"PLoS One"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/antibiotics9070393","article-title":"Augmented renal clearance and how to augment antibiotic dosing","volume":"9","author":"Chen","year":"2020","journal-title":"Antibiotics"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/pharmaceutics9030036","article-title":"Augmented renal clearance in critical illness: an important consideration in drug dosing","volume":"9","author":"Mahmoud","year":"2017","journal-title":"Pharmaceutics"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3390\/ijms23042052","article-title":"Vancomycin-associated acute kidney injury: a narrative review from pathophysiology to clinical application","volume":"23","author":"Kan","year":"2022","journal-title":"Int J Mol Sci."},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/AAC.48.1.63-68.2004","article-title":"In vivo pharmacodynamic activity of daptomycin","volume":"48","author":"Safdar","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:17:42Z","timestamp":1748971062000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001061","relation":{},"ISSN":["0163-4356"],"issn-type":[{"type":"print","value":"0163-4356"}],"subject":[],"published":{"date-parts":[[2023,1,2]]},"assertion":[{"value":"2022-06-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}